These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2338298)

  • 1. Recombinant alpha-2a interferon in the treatment of refractory anemia with excess of blasts.
    Rossi G; Pagetto A; Boverio R; Montanaro G
    Haematologica; 1990; 75(1):97-8. PubMed ID: 2338298
    [No Abstract]   [Full Text] [Related]  

  • 2. Mini-dose interferon alpha-2a in the treatment of myelodysplasia.
    Holcombe RF
    Leukemia; 1993 Feb; 7(2):192-5. PubMed ID: 8426472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant erythropoietin for refractory anemia with ring sideroblasts.
    Musto P; Catalano L; Andriani A; Bodenizza C; Cascavilla N; Di Renzo N; Melillo L; Cicoira L; Carotenuto M; Rotoli B
    Haematologica; 1992; 77(2):185-6. PubMed ID: 1398306
    [No Abstract]   [Full Text] [Related]  

  • 4. Recombinant alpha-2a interferon in HIV-associated myelodysplasia.
    Garavelli PL
    Haematologica; 1988; 73(6):547. PubMed ID: 3148520
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of 5 patients affected by Kaposi's sarcoma and AIDS with recombinant interferon alfa-2A (roferon-A)].
    Lopez Bran E; Aguilar R; Marron JA; Figueredo MA; Garcia Ruiz JM
    Med Cutan Ibero Lat Am; 1989; 17(4):269-73. PubMed ID: 2693866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of recombinant human interferon alpha in myelodysplastic syndromes.
    Nand S; Ellis T; Messmore H; Fisher SG; Gaynor E; Fisher RI
    Leukemia; 1992 Mar; 6(3):220-3. PubMed ID: 1564960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of essential thrombocythaemia by alpha 2a interferon.
    Bellucci S; Harousseau JL; Brice P; Tobelem G
    Lancet; 1988 Oct; 2(8617):960-1. PubMed ID: 2902403
    [No Abstract]   [Full Text] [Related]  

  • 8. [Roferon-A (interferon alfa-2a) permitted for AIDS-associated Kaposi's sarcoma by the BGA].
    Immun Infekt; 1989 Feb; 17(1):VIII. PubMed ID: 2925218
    [No Abstract]   [Full Text] [Related]  

  • 9. Interferon alpha-2a to control thrombocytosis in chronic myelogenous leukemia and essential thrombocythemia.
    Jootar S
    Asian Pac J Allergy Immunol; 1989 Dec; 7(2):103-5. PubMed ID: 2624663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The concept of and countermeasures in refractory anemia].
    Yoshida Y
    Nihon Naika Gakkai Zasshi; 1990 May; 79(5):593-7. PubMed ID: 2199586
    [No Abstract]   [Full Text] [Related]  

  • 11. Recombinant leukocyte interferon alfa-2a in the treatment of mycosis fungoides.
    Simoni R; Cavalieri R; Coppola G; Ricciotti L; De Pità O; Criscuolo D; Covelli A; Papa G; Mandelli F
    J Biol Regul Homeost Agents; 1987; 1(2):93-9. PubMed ID: 3504088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant interferon alfa-2B in refractory idiopathic immune thrombocytopenia.
    Hurtado R; Pita L; Lopez Karpovitch X; Cardenas R; Piedras J; Carrillo S; Labardini J
    Blood; 1990 Apr; 75(8):1744-6. PubMed ID: 2328325
    [No Abstract]   [Full Text] [Related]  

  • 13. Biological characterization of refractory anemia with excess of blasts.
    Maiolo AT; Foa P; Pagetti D; Baldini L; Mozzana R; Ortolani S; Colantoni A; Lombardi L; Lavezzi AM; Polli EE
    Haematologica; 1987; 72(6 Suppl):126-9. PubMed ID: 3127288
    [No Abstract]   [Full Text] [Related]  

  • 14. Complete remission following recombinant interferon alpha-2a in a patient with diffuse large B cell cutaneous lymphoma.
    Tourani JM; Leaute JB; Lessana-Leibowitch M; Andrieu JM
    Nouv Rev Fr Hematol (1978); 1989; 31(4):315-6. PubMed ID: 2691984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-interferon for severe cold agglutinin disease.
    O'Connor BM; Clifford JS; Lawrence WD; Logue GL
    Ann Intern Med; 1989 Aug; 111(3):255-6. PubMed ID: 2502059
    [No Abstract]   [Full Text] [Related]  

  • 16. [Transfusional independence in a patient with refractory anemia with excess blasts-2 refractory to 5-azacitidine treated with deferasirox and colony stimulating factors].
    Moreno de Gusmão B; Guinea de Castro JM; Perez-Persona E; Oiartzabal I
    Med Clin (Barc); 2014 Jan; 142(2):91-2. PubMed ID: 23790532
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of low malignancy non-Hodgkin lymphomas with recombinant interferon. Current status].
    Neubauer A; Herrmann R
    Med Klin (Munich); 1989 Jul; 84(7):355-8. PubMed ID: 2677632
    [No Abstract]   [Full Text] [Related]  

  • 18. Thalidomide abolishes transfusion-dependence in selected patients with myelodysplastic syndromes.
    Musto P; Falcone A; Sanpaolo G; Bisceglia M; Matera R; Carella AM
    Haematologica; 2002 Aug; 87(8):884-6. PubMed ID: 12161367
    [No Abstract]   [Full Text] [Related]  

  • 19. Alpha interferon approved for AIDS-related Kaposi's sarcoma.
    Oncology (Williston Park); 1989 Jan; 3(1):105. PubMed ID: 2641303
    [No Abstract]   [Full Text] [Related]  

  • 20. [Vindesine-interferon alpha-2b combination in the treatment of metastases of cancer of the kidney].
    Coiffier B; Demolombe S; Tabah I
    Presse Med; 1990 May; 19(21):1009. PubMed ID: 2141143
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.